-(1).jpg)
Applying for a grant
Australian Cancer Research Foundation (ACRF) grants
Australian Cancer Research Foundation (ACRF) grants
ACRF awards capital grants (between $1.5 to $5 million) for technology, equipment and infrastructure for cancer research at Australian medical research institutes, hospitals and universities.
Grant applications are open to research into all types of cancer with a research focus on detection, prevention, and/or treatment.
Since 1984, ACRF has awarded $209.3 million to 93 research grants in 44 Australian cancer research institutes.
ACRF promotes collaboration amongst researchers and clinicians and encourages novel and innovative cancer research projects. All applications are competitively reviewed by the ACRF Medical Research Advisory Committee (MRAC) who recommend the best projects to the ACRF Board of Trustees for funding.
2026 annual research grants
Applications for the 2026 ACRF Annual Research Grant Round will open on Monday 9th March 2026 and close on Friday 22rd May 2026.
For further information please refer to 2025 ACRF Annual Grants Guidelines and 2025 Annual Grants Format of Grant Application.
An application template is available by request to [email protected].
For further information please refer to 2025 ACRF Annual Grants Guidelines and 2025 Annual Grants Format of Grant Application.
An application template is available by request to [email protected].
ACRF grants have led to some ground-breaking discoveries
The development of a HPV cervical cancer vaccine
ACRF gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV) vaccine. Over 150 million doses of the vaccine have been delivered worldwide to date.
The uncovering of new breast cancer genes
ACRF has awarded three grants, totalling $8.4 million to QIMR Berghofer, which led to a team of researchers at this Institute discovering at least 12 new genes that influence the risk of developing breast cancer.
The development of a blood test detecting early stages of cancer
ACRF provided $5.5 million in funding to WEHI where researchers developed a blood test that can detect the presence of eight common cancers. The test has been shown to reliably detect early stage and curable cancers.